The efficacy of L- glutamine in sickle cell and sickell thalassemia
Phase 2
- Conditions
- sickle cell and sickell thalassemia.Sickle-cell disorders
- Registration Number
- IRCT20180603039959N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
patients with sickle cell and sickell thalassemia
Exclusion Criteria
Kidney impairment
Renal impaiment
HB <5 gr
Need to emergency transfusion
Pregnancy
Admition more than 10 times
Sensivity to glutamin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect to crisis event. Timepoint: at the end of fourth and eighth week. Method of measurement: pain-admition times-crisis.
- Secondary Outcome Measures
Name Time Method Crisis event. Timepoint: at the end of fourth and eight weeks. Method of measurement: Face Pain Scale.